Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for ViGeneron

    Client Virtual Booth

    VIGENERON

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ViGeneron
    Germany Flag
    Country
    Country
    Germany
    Address
    Address
    Semmelweisstr,3, Planegg, 82152, DE
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vigeneron.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ViGeneron Doses First Patient in VG901 Phase 1b Trial
    ViGeneron Doses First Patient in VG901 Phase 1b Trial

    https://www.globenewswire.com/news-release/2024/04/10/2860550/0/en/ViGeneron-Announces-First-Patient-Dosed-in-Phase-1b-Clinical-Trial-of-VG901-for-the-Intravitreal-Treatment-of-Retinitis-Pigmentosa.html

    GLOBENEWSWIRE
    10 Apr 2024
    Share Share
    Nature publication reveals highly efficient AAV delivery of large genes
    Nature publication reveals highly efficient AAV delivery of large genes

    https://www.globenewswire.com//news-release/2023/10/25/2766475/0/en/Nature-Communications-publication-reveals-highly-efficient-AAV-delivery-of-large-genes-using-ViGeneron-s-REVeRT-technology.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    ViGeneron, Daiichi to develop novel gene therapy for prevalent eye diseases
    ViGeneron, Daiichi to develop novel gene therapy for prevalent eye diseases

    https://www.biospectrumasia.com/news/26/20202/vigeneron-daiichi-sankyo-to-develop-novel-gene-therapy-for-prevalent-eye-diseases.html

    BIOSPECTRUMASIA
    29 Apr 2022
    Share Share
    ViGeneron and Daiichi Sankyo to develop therapy for eye diseases
    ViGeneron and Daiichi Sankyo to develop therapy for eye diseases

    https://www.pharmatimes.com/news/vigeneron_and_daiichi_sankyo_to_develop_therapy_for_eye_diseases_1447608

    Lina Adams PHARMATIMES
    26 Apr 2022
    Share Share
    ViGeneron announces follow-on collaboration with Daiichi Sankyo
    ViGeneron announces follow-on collaboration with Daiichi Sankyo

    https://www.globenewswire.com/news-release/2022/04/26/2428712/0/en/ViGeneron-announces-follow-on-collaboration-with-Daiichi-Sankyo-to-develop-a-novel-gene-therapy-for-prevalent-eye-diseases.html

    GLOBENEWSWIRE
    25 Apr 2022
    Share Share
    ViGeneron signs strategic collaboration and option agreement with Regeneron
    ViGeneron signs strategic collaboration and option agreement with Regeneron

    https://www.globenewswire.com/news-release/2022/04/06/2417228/0/en/ViGeneron-signs-gene-therapy-strategic-collaboration-and-option-agreement-with-Regeneron-for-one-inherited-retinal-disease-target.html

    GLOBENEWSWIRE
    06 Apr 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search